{"schema":"hottub-news/story/v1","story":"st_34n2xl24o2dvt66f5b4q","title":"Novartis (NVS) Has More Growth Ahead. Can its Portfolio Outrun Generic Pressure?","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/novartis-nvs-has-more-growth-ahead-can-its-portfolio-outrun-generic-34n2xl24o2","count":1,"items":[{"id":"n_34n2xl24o2dvt66f5b4q","seq":550146,"kind":"article","title":"Novartis (NVS) Has More Growth Ahead. Can its Portfolio Outrun Generic Pressure?","url":"https://www.insidermonkey.com/news/novartis-nvs-has-more-growth-ahead-can-its-portfolio-outrun-generic-pressure-1845526","published":"2026-09-29T00:43:39Z","seen":"2026-09-29T00:43:39Z","lang":"en","source":{"id":"insidermonkey.com","name":"insidermonkey.com","domain":"insidermonkey.com"},"via":"gdelt-gkg-english","topics":["economy","disaster","business","health"],"authors":["Laiba Immad"],"entities":[{"id":"Q507154","name":"Novartis","type":"org"}],"story":"st_34n2xl24o2dvt66f5b4q","category":"economy-business","category_p":0.8399999737739563,"sentiment":"neutral","tone":0.11999999731779099,"political":0.009999999776482582}]}